PATENT CLAIM ANALYSIS

Application Number: 15771210
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["435", "007100"]

Abstract:
Disclosed are systems and methods for detecting the sample concentration of cardiac troponin I (cTnI) and the sample concentration of soluble urokinase receptor (suPAR) to determine if a subject has or is at risk for developing cardiovascular disease or a complication of previously diagnosed cardiovascular disease.

Claim (Index 22):
The method of  claim 15 , wherein said first assay comprises a single-molecule detection assay.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 91.0
- Lexical Diversity: 1.34211
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12520718', '15062759', '14312298', '13184115', '13798547']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6315117601558884
- 35 USC 102 Novelty (BERT): 0.5153973509599743
- Combined Prediction Score: 0.619900319236297
- Mean Citation Score: 263.76421
- Max Citation Score: 282.89346
- Similarity Product: 170.9749334216988

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test